XML 28 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Shares
ATM Agreement
 [1]
Common Shares
Additional Paid-in Capital
ATM Agreement
 [1]
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Accumulated Other Comprehensive Loss
ATM Agreement
Total
Balance at Dec. 31, 2023   $ 89   $ 111,970 $ (24,576) $ (5,884) $ (1,171)   $ 80,428
Balance (in shares) at Dec. 31, 2023   89,030,436              
Stock-based compensation       463         463
Common stock issued for vested restricted stock units (in shares)   196,991              
Issuance of common stock, net of issuance costs   $ 5 [1]   2,429 [1]       $ 2,400 2,434 [1]
Issuance of common stock, net of issuance costs (in shares)   4,708,993 [1]           4,708,993  
Surrender of common stock for taxes due on vesting       (31)         (31)
Surrender of common stock for taxes due on vesting (in shares)   (76,994)              
Net loss         (45,359)       (45,359)
Balance at Sep. 30, 2024   $ 94   114,831 (69,935) (5,884) (1,171)   37,935
Balance (in shares) at Sep. 30, 2024   93,859,426              
Balance at Jun. 30, 2024   $ 93   114,049 (57,258) (5,884) (1,171)   49,829
Balance (in shares) at Jun. 30, 2024   92,629,246              
Stock-based compensation       184         184
Issuance of common stock, net of issuance costs   $ 1 [2]   598 [2]       $ 600 599 [2]
Issuance of common stock, net of issuance costs (in shares)   1,230,180 [2]           1,230,180  
Net loss         (12,677)       (12,677)
Balance at Sep. 30, 2024   $ 94   114,831 (69,935) (5,884) (1,171)   37,935
Balance (in shares) at Sep. 30, 2024   93,859,426              
Balance at Dec. 31, 2024   $ 96   115,319 (81,077) (5,884) (1,171)   27,283
Balance (in shares) at Dec. 31, 2024   95,661,347              
Stock-based compensation       278         278
Common stock issued for vested restricted stock units (in shares)   577,529              
Issuance of common stock, net of issuance costs $ 25 $ 27 $ 8,615 7,468       $ 8,640 [1] 7,495
Issuance of common stock, net of issuance costs (in shares) 25,139,655 26,736,108           25,139,655  
Surrender of common stock for taxes due on vesting       (93)         (93)
Surrender of common stock for taxes due on vesting (in shares)   (283,642)              
Equity settlement of PSUs and DSUs       42         42
Equity settlement of PSUs and DSUs (in shares)   66,240              
Issuance of equity to settle the loan   $ 14   6,378         6,392
Issuance of equity to settle the loan (shares)   14,204,846              
Warrants       385         385
Net loss         (24,460)       (24,460)
Balance at Sep. 30, 2025   $ 162   138,392 (105,537) (5,884) (1,171)   25,962
Balance (in shares) at Sep. 30, 2025   162,102,083              
Balance at Jun. 30, 2025   $ 137   126,958 (100,882) (5,884) (1,171)   19,158
Balance (in shares) at Jun. 30, 2025   136,786,129              
Stock-based compensation       72         72
Issuance of common stock, net of issuance costs   $ 11   4,984         4,995
Issuance of common stock, net of issuance costs (in shares)   11,111,108           0  
Issuance of equity to settle the loan   $ 14   6,378         6,392
Issuance of equity to settle the loan (shares)   14,204,846              
Net loss         (4,655)       (4,655)
Balance at Sep. 30, 2025   $ 162   $ 138,392 $ (105,537) $ (5,884) $ (1,171)   $ 25,962
Balance (in shares) at Sep. 30, 2025   162,102,083              
[1] An aggregate of 25,139,655 shares of the Company’s common stock were sold through the ATM Program during the nine months ended September 30, 2025, for proceeds of approximately $8.6 million to the Company, after deducting the agent’s commissions and other fees. 4,708,993 shares of the Company’s common stock were sold through the ATM Program during the nine months ended September 30, 2024, for proceeds of approximately $2.4 million to the Company, after deducting the agent’s commissions and other fees. Please also see Note—15 Shareholder’s Equity in Item 1—Condensed Consolidated Interim Financial Statements and Notes (unaudited) for additional information.
[2] No shares of the Company’s common stock were sold through the ATM Program during the three months ended September 30, 2025. 1,230,180 shares of the Company’s common stock were sold through the ATM Program during the three months ended September 30, 2024, for net proceeds of approximately $0.6 million to the Company, after deducting the agent’s commissions and other fees. Please also see Note—16 Shareholder’s Equity in Item 1—Condensed Consolidated Interim Financial Statements and Notes (unaudited) for additional information.